UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform... Show more
UiPath is an enterprise automation and AI software company known for pioneering robotic process automation (RPA). Its platform helps organizations automate repetitive digital tasks, orchestrate complex workflows, and increasingly deploy AI-powered agents across business operations. Over recent years, the company has repositioned itself around "agentic automation," combining traditional, deterministic automation with AI capabilities that can perform more dynamic, decision-oriented work.
UiPath competes in the broader enterprise workflow and automation market against players such as ServiceNow, Pegasystems, and Salesforce. Investors follow the stock closely because UiPath sits at the intersection of several high-profile technology themes, including generative AI, workflow automation, and intelligent business operations, while also carrying a substantial recurring-revenue base.
Over the last 30 days, PATH shares advanced approximately 44%, climbing from a closing price of roughly $12.59 to around $18.15. The rally was not linear: the stock initially traded near its late-July lows before gaining momentum through August, punctuated by several strong single-session advances.
The quarterly trend tells a similar story of recovery. From the lows reached in late July, when shares traded near $10, UiPath rebounded sharply, and the stock has gained more than 40% over the trailing three-month window. This momentum stands in contrast to a weaker year-to-date picture earlier in 2026, when UiPath traded in a relatively narrow range as investors questioned the impact of AI on its business model.
The most important catalyst behind the move was a combination of improving fundamentals and a broad re-rating of enterprise software. UiPath's most recent reported quarter delivered revenue growth of approximately 17% year over year, and, critically, the company posted its first-ever GAAP-profitable quarter. Management also pointed to agentic AI products "moving from pilot to production," signaling that customers are beginning to deploy these capabilities at scale.
Product momentum added further fuel. UiPath introduced new offerings aimed at coding agents, extending its platform to orchestrate and govern AI coding workflows, and continued to expand its Maestro platform for case and workflow management. These launches reinforced the view that UiPath is actively embracing AI rather than being disrupted by it.
The rally was also amplified by sector-wide strength. Strong earnings from high-profile AI and software peers helped lift sentiment across the group, encouraging investors to rotate back into growth-oriented technology names. Analyst actions followed suit, with firms such as RBC Capital and Barclays raising their price targets on PATH. Notably, the stock's advance occurred ahead of UiPath's next earnings release, indicating that investors were repositioning in anticipation of continued progress.
Over the past quarter, UiPath's rebound reflects a broader narrative shift rather than a single news event. After spending much of the first half of 2026 under pressure, the stock recovered as investors reassessed the company's ability to monetize AI. The transition from pilot programs to production deployments of agentic automation, combined with evidence of larger enterprise deals, suggested that UiPath's platform could benefit from rising enterprise AI spending.
The profitability milestone was central to this reassessment. Moving from losses to GAAP operating income gave investors greater confidence in the durability of the business model and its capacity to fund continued investment in AI and go-to-market efforts. Improving large-customer metrics, including growth in the number of accounts generating more than $100,000 in annual recurring revenue, further supported the case that UiPath is deepening its position within enterprise accounts.
For traders seeking a data-driven approach to stock selection, Tickeron's Trending AI Robots page offers a curated view of AI-powered trading bots. Tickeron provides hundreds of AI trading bots that trade thousands of tickers, but only the top-performing and most relevant bots are featured in this section. The bots vary widely in strategy, timeframe, and performance metrics, allowing users to explore approaches that align with different trading styles and risk preferences. The curated list is designed to help investors identify automated strategies that are currently demonstrating strength across the market.
Looking ahead, the primary near-term catalyst is UiPath's upcoming quarterly earnings report, scheduled for early September 2026. Investors will focus on revenue growth, annual recurring revenue (ARR) trends, net new ARR, and any updates to full-year guidance. Analysts have noted that revenue growth is expected to moderate sequentially, and the relationship between reported revenue growth and ARR growth will be closely scrutinized as a gauge of subscription-quality expansion.
Beyond earnings, key factors include the pace of agentic AI adoption, competitive dynamics with larger workflow and AI platforms, macroeconomic conditions affecting enterprise technology budgets, and any shifts in analyst estimates. Valuation remains a point of debate, as the sharp rally has moved the stock above some analysts' consensus price targets. These dynamics will likely shape sentiment around PATH in the months ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
PATH saw its Momentum Indicator move below the 0 level on September 04, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 74 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 89%.
The 10-day RSI Indicator for PATH moved out of overbought territory on September 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In 16 of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.
The Moving Average Convergence Divergence Histogram (MACD) for PATH turned negative on September 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 37 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
PATH moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 50-day moving average for PATH moved above the 200-day moving average on August 26, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +10.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where PATH advanced for three days, in 227 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
PATH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 119 of 163 cases where PATH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.678) is normal, around the industry mean (22.181). P/E Ratio (20.522) is within average values for comparable stocks, (120.106). Projected Growth (PEG Ratio) (0.504) is also within normal values, averaging (1.993). PATH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (4.286) is also within normal values, averaging (109.949).
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. PATH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications